Among his notable achievements, Dr. Donald E. Ingber is most renowned for his founding of the fields of mechanobiology, tumor angiogenesis, and biologically inspired engineering.
BOSTON, MA, January 31, 2019 /24-7PressRelease/ -- Marquis Who's Who, the world's premier publisher of biographical profiles, is proud to present Donald E. Ingber, MD, Ph.D., with the Albert Nelson Marquis Lifetime Achievement Award. An accomplished listee, Dr. Ingber celebrates many years of experience in his professional network, and has been noted for achievements, leadership qualities, and the credentials and successes he has accrued in his field. As in all Marquis Who's Who biographical volumes, individuals profiled are selected on the basis of current reference value. Factors such as position, noteworthy accomplishments, visibility, and prominence in a field are all taken into account during the selection process.
With more than 30 years of professional experience, Dr. Ingber has been the Founding Director of the Wyss Institute for Biologically Inspired Engineering at Harvard University since 2009, the Judah Folkman Professor of Vascular Biology at Harvard Medical School and Boston Children's Hospital since 2004, and professor of pathology with the school from 1999 to 2016. In addition to his primary roles, he has served as a professor of bioengineering with the John A. Paulson School of Engineering and Applied Sciences at Harvard University since 2008. Earlier in his career, Dr. Ingber was an associate professor of pathology at Brigham and Women's Hospital from 1992 to 1999, where he was previously an assistant professor of pathology from 1988 to 1992 and an instructor of pathology from 1986 to 1988.
Dr. Ingber began his career as a student at Yale University, where he obtained a Bachelor of Arts and a Master of Arts in 1977. He continued his studies with the university, completing a Master of Philosophy in 1981. He concluded his education in 1984, earning a Doctor of Medicine and Doctor of Philosophy. Dr. Ingber then joined Harvard Medical School and Boston Children's Hospital for a fellowship from 1984 to 1986.
A respected voice in his industry, Dr. Ingber has been affiliated with a number of professional organizations. He is a member of the American Association for the Advancement of Science, the American Society for Cell Biology, the American Association for Cancer Research, the American Society for Clinical Pathology, the American Physical Society, and the North American Vascular Biology Organization. He has also been active with the Society for Biomaterials, the Society for Developmental Biology, the Society for In Vitro Biology, the Tissue Culture Society, the American Society for Gravitational and Space Research, and the Materials Research Society.
Among his notable achievements, Dr. Ingber is most renowned for his founding of the fields of mechanobiology, tumor angiogenesis, and biologically inspired engineering. He is an inventor on more than 190 patents for organs-on-chips, angiogenesis inhibitors, biomimetic materials, medical devices, filtration systems, computer software and tissue engineering applications. Likewise, he developed the "Tensegrity Model" for cell and tissue architecture and discovered a new class of anti-cancer drugs which inhibit blood vessel growth. He further demonstrated the importance of extracellular matrix, integrins and mechanical forces as regulators in tissue development. Dr. Ingber has contributed over 450 articles to professional journals and chapters to books. Through his work, Ingber also has helped to break down boundaries between science, art and design.
Throughout his career, Dr. Ingber has received myriad awards and accolades for his achievements. He has been elected to the U.S. National Academy of Medicine, National Institute of Inventors, American Academy of Arts and Sciences, and American Institute for Medical and Biological Engineering. He also has been the recipient of multiple scholarships and pre-doctoral and postdoctoral fellowships early in his career, as well as the Breast Cancer Innovator Award from the Department of Defense in 2009, a Lifetime Achievement Award from the Society for In Vitro Biology, Robert A. Pritzker Award from the Biomedical Engineering Society, and Rous Whipple Award from the American Society of Investigative Pathology in 2010. Later on, he received a Webby Award for Science from the International Academy of Digital Arts and Sciences in 2012, a Leading Edge Award from the Society of Toxicology in 2013, and a Shu Chien Award from the Biomedical Engineering Society in 2016. Most recently, he was the recipient of a Pioneer Award from the University of Pittsburgh in 2017 and a Founder's Award from the Biophysical Society in 2018. He also was named one of the Top 20 Translational Researchers world-wide in 2012 (Nature Biotechnology), a Leading Global Thinker of 2015 (Foreign Policy magazine), and one of the most highly cited scientists by Clarivate Analytics in 2018. In 2013, Ingber's work on Organs-on-Chips was honored by the NC3Rs Annual Award from the National Centre for the Replacement, Refinement, and Reduction of Animals in Research, London; in 2015, this technology was named Design of the Year by the London Design Museum and was also acquired by the Museum of Modern Art (MoMA) in New York City for its permanent design collection; and in 2016, they were named one of the Top 10 Emerging Technologies of 2016 by the World Economic Forum. Furthermore, he has been featured in numerous honors publications, including multiple editions of Who's Who in America, Who's Who in Medicine and Healthcare, Who's Who in Science and Engineering, Who's Who in the East and Who's Who in the World.
In recognition of outstanding contributions to his profession and the Marquis Who's Who community, Dr. Ingber has been featured on the Albert Nelson Marquis Lifetime Achievement website. Please visit www.ltachievers.com for more information about this honor.
About Marquis Who's Who®
Since 1899, when A. N. Marquis printed the First Edition of Who's Who in America®, Marquis Who's Who® has chronicled the lives of the most accomplished individuals and innovators from every significant field of endeavor, including politics, business, medicine, law, education, art, religion and entertainment. Today, Who's Who in America® remains an essential biographical source for thousands of researchers, journalists, librarians and executive search firms around the world. Marquis® now publishes many Who's Who titles, including Who's Who in America®, Who's Who in the World®, Who's Who in American Law®, Who's Who in Medicine and Healthcare®, Who's Who in Science and Engineering®, and Who's Who in Asia®. Marquis® publications may be visited at the official Marquis Who's Who® website at www.marquiswhoswho.com.
# # #